Additionally, ITGAL, ITGAX, and IIT possessed effective ICB biomarker potentials towards glioblastoma, melanoma, gastric cancer, and others, with analogous effectiveness compared to well-established ICB biomarkers (Figure S2C–F). This evidence concerns the gene ITGAL and gastric cancer.